Private Advisor Group’s Oragenics OGEN Stock Holding History

Private Advisor Group’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1	Closed	-$1K	–	2829
2020 Q2	$1K	Buy	+1	New	+$984	﹤0.01%	3735

Other funds holding OGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBF

Sara-Bay Financial Sarasota, Florida $375M AUM 56.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Private Advisor Group's OGEN Position: Q3 2020 in Review

Private Advisor Group sold out of Oragenics (OGEN) in Q3 2020, closing a stake of 1 share — an estimated $1K sold.

Private Advisor Group first reported a position in OGEN in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 16 funds tracked by Wall St. Rank hold OGEN as of Q3 2020.

Private Advisor Group reported no remaining Oragenics position as of Q3 2020 after selling out during the quarter.
Private Advisor Group sold 1 Oragenics share in Q3 2020, an estimated $1K.
Private Advisor Group first reported a position in Oragenics in Q2 2020 and held it in 1 quarter.
Private Advisor Group's Oragenics position peaked at $1K in Q2 2020.
16 funds tracked by Wall St. Rank held Oragenics as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.